LOW-GRADE SEROUS OVARIAN CARCINOMA (LGSOC)

Clinical trials for LOW-GRADE SEROUS OVARIAN CARCINOMA (LGSOC) explained in plain language.

Never miss a new study

Get alerted when new LOW-GRADE SEROUS OVARIAN CARCINOMA (LGSOC) trials appear

Sign up with your email to follow new studies for LOW-GRADE SEROUS OVARIAN CARCINOMA (LGSOC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a breast cancer pill keep ovarian cancer at bay?

Disease control Recruiting now

This large Phase 3 trial is testing whether adding the drug letrozole to standard maintenance therapy helps prevent ovarian cancer from coming back. It will involve 540 women with ER-positive ovarian, fallopian tube, or peritoneal cancer who have completed initial surgery and che…

Matched conditions: LOW-GRADE SEROUS OVARIAN CARCINOMA (LGSOC)

Phase: PHASE3 • Sponsor: Swiss GO Trial Group • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

LOW-GRADE SEROUS OVARIAN CARCINOMA (LGSOC)

Get alerted when new LOW-GRADE SEROUS OVARIAN CARCINOMA (LGSOC) trials appear

Could a breast cancer pill keep ovarian cancer at bay?